Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Clinical trial NCT01629082 · COMPLETED

Trial details

NCT number: NCT01629082
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myeldysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia Bone Marrow Diseases Neutropenia Acute Myeloid Leukemia (AML)

Start date: 2012-06-06
Primary completion: 2015-10-27
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.